PG vs STOK · P/E 25, rev $84.28B vs rev $36.6M
Procter & Gamble Company (PG) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
PG currently screens at market cap $373.53B and trailing P/E 25.3. STOK currently screens at market cap $1.88B.
Not investment advice. Open the PG and STOK stock pages for the full models.
Not investment advice.